Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Agnarsson, Bjarni AGudbjartsson, Tomas
Einarsson, Gudmundur Vikar
Magnusson, Kjartan
Thoroddsen, Asgeir
Bergthorsson, Jon Thor
Amundadottir, Laufey T
Barkardottir, Rosa B
Björnsson, Johannes
Issue Date
2006-11-01
Metadata
Show full item recordCitation
APMIS 2006, 114(11):779-83Abstract
The purpose of this study was to examine the pathology of all germ cell tumours of the testis diagnosed in Iceland 1955-2002. A total of 214 patients were included in the study. The current age-standardized incidence was found to be 6.1 per 100,000 and had increased almost fourfold during the study period. Seminoma was diagnosed in 55% of cases. Non-seminomas were diagnosed in 45%, and these were further classified as mixed germ cell tumours (33%), embryonal carcinoma (8%), teratoma (3%), and yolk sac tumour (n=1). The mean age at diagnosis was significantly higher for the seminomas than the non-seminomas (38 years versus 29 years) (p<0.001) and the non-seminomas were diagnosed at a significantly higher stage than the seminomas (p<0.001). Thus, in seminoma patients the tumour was localized to the testis (stage I) in 81% of cases, in 17% of patients the tumour had spread to the lymph nodes (stage II or III), and only 2% had extranodal metastasis at diagnosis (stage IV). In contrast, in the non-seminoma patients, the tumours were found to be stage I in 56%, stage II or III in 24%, and stage IV in 20% of cases. No significant difference in staging was found between non-seminoma subtypes. Identification of necrosis or vascular invasion was significantly associated with metastatic disease at diagnosis (p=0.002). During the study period a significant increase in stage I tumours was found as well as a decrease in the size of the tumours.Description
To access Publisher full text version of this article. Please click on the hyperlink in Additional Links fieldae974a485f413a2113503eed53cd6c53
10.1111/j.1600-0463.2006.apm_468.x
Scopus Count
Collections
Related articles
- [Clinical presentation of testicular germinal cancer].
- Authors: Fernández Gómez JM, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, Escaf Barmadah S, García Rodríguez J, Pérez García FJ, Rodríguez Faba O, Jalón Monzón A
- Issue date: 2002 Oct
- [Urologic treatment of testicular germ cell cancer].
- Authors: Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ
- Issue date: 2002 Oct
- The changing distribution of pT stage in testicular germ cell tumours from 1976 to 2005: a single-centre analysis of histopathological reports.
- Authors: Lackner JE, Koller A, Mazal PR, Waldert M, Waldhoer T, Marberger M, Kratzik C
- Issue date: 2006 Oct
- Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma.
- Authors: Yakirevich E, Lefel O, Sova Y, Stein A, Cohen O, Izhak OB, Resnick MB
- Issue date: 2002 Jan
- [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
- Authors: Neumann A, Keller T, Jocham D, Doehn C
- Issue date: 2011 Sep